Olmesartan: all 21 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Multi-Omics to Predict the Blood Pressure Response to AntihypertensivesRecruitingNCT05917275Phase 4
- Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in HypertensionCompletedNCT00902538Phase 3Results posted
- Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential HypertensionCompletedNCT00696241Phase 3Results posted
- Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose IntoleranceCompletedNCT00122447Not applicableResults posted
- Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and HypertensionCompletedNCT05189015Phase 4
- Clinical Trial to Evaluate Pharmacokinetic Interaction of ATB-1011 and ATB-1012 in Healthy Adult VolunteersCompletedNCT04856969Phase 1
- Effect of Olmesartan and Nebivolol on Ambulatory Blood Pressure and Arterial Stiffness in Acute Stage of Ischemic StrokeCompletedNCT03655964Phase 2
- Use of Impedance Cardiography and Applanation Tonometry for Prediction of the Antihypertensive Effect of Two DrugsCompletedNCT03560804Not applicable
- Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose TissueStatus unknownNCT02996916Phase 4
- The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic DiseaseStatus unknownNCT02516826Phase 2
- Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension ControlWithdrawnNCT02493322Phase 3
- Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension ControlWithdrawnNCT02483936Phase 3
- Effect of olmesaRtan on Walking distancE and quaLIty of lifE in Peripheral Artery Disease Patients With Hypertension Treated For Intermittent Claudication (RELIEF)TerminatedNCT02373462Phase 4
- Investigation of Pharmacokinetic Interaction Between Rosuvastatin and Olmesartan in Healthy Male VolunteersCompletedNCT01831479Phase 1
- Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mgCompletedNCT01611077Phase 4
- Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic SyndromeStatus unknownNCT01271374Phase 4
- Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure StudyWithdrawnNCT01089452Phase 4
- Effects of Antihypertensive Drugs in Patients With Hypertension and Obstructive Sleep Apnea (OSA)CompletedNCT01028534Not applicable
- Renin Profiling in Selection of Initial Antihypertensive DrugCompletedNCT00834600Not applicable
- Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk AssessmentCompletedNCT00741585Phase 4
- Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial FibrillationCompletedNCT00098137Phase 3